TECON(002100)
Search documents
9月10日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-10 10:38
Group 1 - Dematech won a 900 million yuan overseas smart logistics project from a well-known e-commerce giant in Latin America, focusing on intelligent logistics cross-belt sorting systems and related services [1] - Kang En Bei received approval for the registration of short-term financing bonds and medium-term notes, with a total registration amount of 1 billion yuan, valid for two years [1][2] - Zhi Xiang Jin Tai's GR1803 injection for systemic lupus erythematosus clinical trial has been approved by the National Medical Products Administration [2] Group 2 - Jin Da Wei's subsidiary received approval for a veterinary drug product, pyridone, valid from September 3, 2025, to September 2, 2030 [4] - Fu Li Wang's subsidiary plans to invest 500 million yuan in a high-end wire material project, focusing on high-strength prestressed steel strands for various applications [5] - He Li Biological's subsidiary's Class III medical device registration application has been accepted, focusing on natural bone repair materials [12] Group 3 - Lin Yang Energy won a 244 million yuan metering equipment project from Southern Power Grid, expected to positively impact its 2025 and 2026 performance [20] - Sanxia Water plans to absorb its wholly-owned subsidiary, Chongqing Changdian United Energy, with all assets and liabilities to be inherited by Sanxia Water [13] - Tian Cheng Technology canceled the use of 91 million yuan of raised funds for permanent working capital, ensuring no impact on the normal operation of investment projects [24] Group 4 - Baosteel received approval to publicly issue bonds totaling 20 billion yuan to professional investors, valid for 24 months [52] - Tian Kang Biological reported a 10.15% year-on-year increase in pig sales in August, with a total of 263,800 pigs sold [53] - Xinjiang Construction won multiple major projects totaling 4.506 billion yuan, including a 2.4 billion yuan photovoltaic hydrogen synthesis project [18]
天康生物:公司将继续通过技术升级和管理提升,致力于成本的持续优化
Zheng Quan Ri Bao Zhi Sheng· 2025-09-10 08:09
证券日报网讯 天康生物9月10日在互动平台回答投资者提问时表示,公司通过持续的生产管理优化与精 准饲喂策略,8月份的生猪养殖成本已降至12.6元/kg,其中自繁自养出栏肥猪成本已降至11.8元/kg,公 司将继续通过技术升级和管理提升,致力于成本的持续优化。 (编辑 王雪儿) ...
天康生物:8月份的生猪养殖成本已降至12.6元/kg,其中自繁自养出栏肥猪成本已降至11.8元/kg
Mei Ri Jing Ji Xin Wen· 2025-09-10 04:38
每经AI快讯,有投资者在投资者互动平台提问:请问公司八月份的成本有下降吗?现在是什么水平? 天康生物(002100.SZ)9月10日在投资者互动平台表示,公司通过持续的生产管理优化与精准饲喂策 略,8月份的生猪养殖成本已降至12.6元/kg,其中自繁自养出栏肥猪成本已降至11.8元/kg,公司将继续 通过技术升级和管理提升,致力于成本的持续优化。 (文章来源:每日经济新闻) ...
天康生物:8月份生猪养殖成本已降至12.6元/kg
Zheng Quan Shi Bao Wang· 2025-09-10 03:40
人民财讯9月10日电,天康生物(002100)在互动平台上表示,公司通过持续的生产管理优化与精准饲喂 策略,8月份的生猪养殖成本已降至12.6元/kg,其中自繁自养出栏肥猪成本已降至11.8元/kg。 转自:证券时报 ...
天康生物:8月销售简报
Zheng Quan Ri Bao Wang· 2025-09-09 13:42
证券日报网讯9月9日晚间,天康生物(002100)发布公告称,2025年8月份销售生猪26.38万头,销量环 比增长18.03%,同比增长10.15%,销售收入3.80亿元,销售收入环比增长13.43%,同比下降17.03%。 商品猪(扣除仔猪、种猪后)销售均价12.79元/公斤,环比下降6.09%。 ...
天康生物:8月份生猪销售收入3.80亿元,同比下降17.03%
Xin Lang Cai Jing· 2025-09-09 11:04
天康生物9月9日公告,公司2025年8月份销售生猪26.38万头,销量环比增长18.03%,同比增长10.15%; 销售收入3.80亿元,销售收入环比增长13.43%,同比下降17.03%。2025年8月份商品猪(扣除仔猪、种 猪后)销售均价12.79元/公斤,环比下降6.09%。2025年1-8月,公司累计销售生猪201.55万头,较去年 同期增长8.24%;累计销售收入29.58亿元,较去年同期下降4.89%。 ...
天康生物(002100.SZ):8月生猪销售收入3.80亿元 同比下降17.03%
智通财经网· 2025-09-09 11:01
智通财经APP讯,天康生物(002100.SZ)发布公告,公司2025年8月份销售生猪26.38万头,销量环比增长 18.03%,同比增长10.15%;销售收入3.80亿元,销售收入环比增长13.43%,同比下降17.03%。 1-8月,公司累计销售生猪201.55万头,较去年同期增长8.24%;累计销售收入29.58亿元,较去年同期下 降4.89%。 ...
天康生物(002100.SZ):8月生猪销售收入3.8亿元
Ge Long Hui A P P· 2025-09-09 10:58
Group 1 - The core point of the article is that TianKang Biological (002100.SZ) reported an increase in pig sales in August 2025, with a total of 263,800 pigs sold, representing a month-on-month growth of 18.03% and a year-on-year growth of 10.15% [1] - The sales revenue for August 2025 reached 380 million yuan, showing a month-on-month increase of 13.43% but a year-on-year decrease of 17.03% [1] - The average selling price of commercial pigs (excluding piglets and breeding pigs) in August 2025 was 12.79 yuan per kilogram, which is a month-on-month decrease of 6.09% [1] Group 2 - For the period from January to August 2025, the company sold a total of 2,015,500 pigs, which is an increase of 8.24% compared to the same period last year [1] - The cumulative sales revenue for the first eight months of 2025 was 2.958 billion yuan, reflecting a year-on-year decrease of 4.89% [1]
天康生物:8月销售生猪收入3.8亿元 环比增长13.43%
Zheng Quan Shi Bao Wang· 2025-09-09 10:53
人民财讯9月9日电,天康生物(002100)9月9日晚间公告,2025年8月份销售生猪26.38万头,环比增长 18.03%,同比增长10.15%;销售收入3.80亿元,环比增长13.43%,同比下降17.03%。2025年8月份商品 猪(扣除仔猪、种猪后)销售均价12.79元/公斤,环比下降6.09%。2025年1—8月,公司累计销售生猪 201.55万头,较去年同期增长8.24%;累计销售收入29.58亿元,较去年同期下降4.89%。 ...
天康生物:8月份生猪销售收入3.8亿元,同比下降17.03%
Xin Lang Cai Jing· 2025-09-09 10:51
天康生物公告,2025年8月份公司销售生猪26.38万头,环比增长18.03%,同比增长10.15%;销售收入为 3.8亿元,环比增长13.43%,同比下降17.03%。商品猪销售均价为12.79元/公斤,环比下降6.09%。1-8月 累计销售生猪201.55万头,同比增长8.24%;累计销售收入为29.58亿元,同比下降4.89%。 ...